Xwell XWEL
NASDAQ XWEL
$0.90 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Xwell (XWEL) Research & Development (2010 - 2023)

Xwell's (XWEL) quarterly Research & Development came in at $273000.0 in Q3 2023, down 63.16% year-over-year from $741000.0 in Q3 2022, and up 33.82% quarter-over-quarter from $204000.0 in Q2 2023.

Analysis

Xwell (XWEL) Research & Development (2010 - 2023) Analysis & Trends

Xwell has disclosed Research & Development across 9 years of filings, most recently posting $273000.0 for Q3 2023.

  • In Q3 2023, Research & Development fell 63.16% year-over-year to $273000.0; the TTM figure through Sep 2023 stood at $2.1 million (down 74.83% YoY), while the FY2014 annual figure was $889000.0, down 41.2% from the prior year.
  • Research & Development came in at $273000.0 for Q3 2023 at Xwell, up from $204000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $839000.0 in Q2 2022 to a low of $204000.0 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Valvoline 3.41 Bn 3.33 Bn 214.90 Mn -
2 Onespaworld Holdings 2.22 Bn 2.18 Bn 84.35 Mn -
3 Driven Brands Holdings 2.03 Bn 1.84 Bn - -
4 Boyd Group Services 1.83 Bn 1.81 Bn 480.03 Mn -
5 Charming Medical 445.47 Mn 439.45 Mn - -
6 Ww International 160.94 Mn -5.63 Mn -27.69 Mn -
7 Regis 66.74 Mn 66.74 Mn - -
8 Vanguard Green Investment 33.28 Mn 33.28 Mn - -
9 SUPA Consolidated 14.54 Mn 14.53 Mn - -
10 Xwell 7.62 Mn 5.95 Mn 2.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 273,000.00
Jun 30, 2023 204,000.00
Sep 30, 2022 741,000.00
Jun 30, 2022 839,000.00
Sep 30, 2017 3.90 Mn
Jun 30, 2017 2.69 Mn
Mar 31, 2017 2.96 Mn
Sep 30, 2016 1.55 Mn
Jun 30, 2016 2.18 Mn
Mar 31, 2016 1.13 Mn
Dec 31, 2014 219,000.00
Sep 30, 2014 228,000.00
Jun 30, 2014 217,000.00
Mar 31, 2014 225,000.00
Dec 31, 2013 233,000.00
Sep 30, 2013 542,000.00
Jun 30, 2013 467,000.00
Mar 31, 2013 270,000.00
Dec 31, 2012 -454,000.00
Sep 30, 2012 997,000.00